SABBY 13G PHIO 2.11.20

Company

Phio Pharmaceuticals Corp.

Filed

February 11, 2020

Accession Number

0001535610-20-000069

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →